Table 4 The clinical and histopathologic characteristics of the patients with HMGB1 overexpression who died during the follow-up period.
From: Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas
No. | Gender | Age | Survival Time(m) | pTNM Stage | Grade |
|---|---|---|---|---|---|
1 | male | 75 | 15 | T4N1M1 | G1 |
2 | male | 69 | 23 | T3N1M0 | G2 |
3 | female | 48 | 12 | T3N1M0 | G3 |
4 | male | 66 | 12 | T3N3M0 | G3 |
5 | male | 65 | 11 | T3N3M0 | G3 |
6 | female | 51 | 9 | T4N1M0 | G4 |
7 | male | 61 | 10 | T4N1M0 | G4 |
8 | female | 58 | 7 | T3N2M0 | G2 |
9 | male | 68 | 8 | T3N2M0 | G2 |
10 | male | 52 | 11 | T3N2M0 | G4 |
11 | male | 69 | 10 | T4N1M0 | G3 |
12 | female | 75 | 14 | T4N2M0 | G4 |